Asian Insight Provider - Actionable ideas, CrossASEAN Research

Henry Soediarko

A Long & Short Investment Ideas generator for Asian Equities with 10 years experience in a Hedge fund focused on bottom-up ideas, searching out mispriced ideas and misunderstood investment thesis. Provides on-the-ground insights in various Asian markets with a sway towards ASEAN. Experienced and survived the Asian Financial Crisis in a family business, as well as the Global Financial Crisis in financial markets where lessons learned. It's all about understanding business drivers and navigating business cycles, which has high applicability in generating investment ideas. 

Investment horizon: Mid to Long term

Asian Insight Provider - Actionable ideas

TESLA (TSLA US): A Forensic Valuation of the World's Most Contested Stock

Investment Thesis - Valuation Summary: Tesla Inc. - July 14, 2026

CrossASEAN Research

At CrossASEAN Research we strive to produce unbiased and differentiated on the ground insights on companies across South East Asia. Our Research is produced for the most part after face to face meetings and conversations with company management to dig deep into the long term vision and strategy of the companies we cover. We seek to deliver investable and actionable themes on sectors and markets across SE Asia, often in collaboration with other Insight Providers across the region, pooling the vast experience of the analysts within the Smartkarma Ecosystem. We also offer bespoke work and tailor made trips for our clients. 

Insights across South East Asia

Equity Bottom-Up

<ul>
<li>
<a href="https://www.smartkarma.com/entities/tesla-inc" target="_blank" data-smartkarma-citation="entities:20279:1" rel="noopener">Tesla (TSLA US)</a> reported a sharp contrast between revenue growth and margin erosion. The statewide approval is efficient, but it will not happen next year either. </li>
<li>The management warned of high CapEx that will keep free cash flow under pressure. </li>
<li>No indication of turnaround yet; thus, it is not too late to short the stock. </li>
</ul>



Tesla (TSLA US) reported a sharp contrast between revenue growth and margin erosion. The statewide approval is efficient, but it will not happen next year either. 
The management warned of high CapEx that will keep free cash flow under pressure. 
No indication of turnaround yet; thus, it is not too late to short the stock. 


Tesla

Tesla (TSLA): High CapEx on Sight